In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Laura Chambers to discuss the low-risk population in advanced ovarian cancer. Laura Chambers, DO is an Assistant Professor in the Division of Gynecologic Oncology at The James Cancer Center at The Ohio State University.

Highlights:

- Discuss historical perspectives of low and high-risk ovarian cancer, and how this has been analyzed in contemporary trials

- Review of contemporary trials for PARPi and Bevacizumab maintenance in women with advanced ovarian cancer

- Data obtained through un-powered sub-analysis from randomized clinical trials is hypothesis generating and care must be exercised in applying this to patient cohorts